RMD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RMD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
ResMed's Revenue per Share for the three months ended in Sep. 2024 was $8.30.
During the past 12 months, ResMed's average Revenue per Share Growth Rate was 9.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 13.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 12.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 11.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of ResMed was 32.30% per year. The lowest was 7.90% per year. And the median was 15.40% per year.
For the Medical Instruments & Supplies subindustry, ResMed's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, ResMed's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where ResMed's 3-Year Revenue Growth Rate falls into.
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
ResMed (NYSE:RMD) 3-Year Revenue Growth Rate Explanation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Thank you for viewing the detailed overview of ResMed's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Peter C Farrell | director | RESMED INC, 14040 DANIELSON STREET, POWAY CA 92064-6857 |
Michael J Rider | officer: Global General Counsel | 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123 |
Michael J. Farrell | officer: Chief Executive Officer | C/O REMED INC, 9001 SPECTRUM CTR. BLVD., SAN DIEGO, CA 92123 |
Justin Leong | officer: President, Asia and LATAM | C/O RESMED INC, 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123 |
Witte Jan De | director | C/O RESMED INC., 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123 |
Brett Sandercock | officer: Chief Financial Officer | 17 GUINEVIERE COURT, CASTLE HILL, NEW SOUTH WALES C3 2154 |
Kaushik Ghoshal | officer: President, SaaS Business | 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123 |
Karen Drexler | director | C/O DIADEXUS, INC., 343 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080 |
Robert Andrew Douglas | officer: President and COO | 21 ATTUNGA ROAD, NEWPORT, NEW SOUTH WALES C3 2106 |
David Pendarvis | officer: Chief Administration Officer | REDMED INC, 14040 DANLELSON ST, POWAY CA 92064 |
Desney Tan | director | 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123 |
John Hernandez | director | 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123 |
Lucile Blaise | officer: President, Sleep & RC Business | RESMED INC., 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123 |
James Hollingshead | officer: President, Sleep Business | C/O RESMED INC., 9001 SPECTRUM CENTER BOULEVARD, SAN DIEGO CA 92123 |
Carol Burt | director | C/O WELLCARE HEALTH PLANS, INC., 8725 HENDERSON ROAD, TAMPA FL 33634 |
From GuruFocus
By GuruFocus News • 11-22-2024
By GuruFocus News • 12-06-2024
By GuruFocus Research • 09-11-2024
By GuruFocus News • 11-08-2024
By GuruFocus News • 10-25-2024
By GuruFocus Research • 09-14-2024
By Marketwired • 09-10-2024
By Marketwired • 10-24-2024
By Marketwired • 09-30-2024
By GuruFocus News • 10-24-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.